PT2898888T - Composição que compreende iota-carragenina contra conjuntivite viral - Google Patents

Composição que compreende iota-carragenina contra conjuntivite viral

Info

Publication number
PT2898888T
PT2898888T PT14152188T PT14152188T PT2898888T PT 2898888 T PT2898888 T PT 2898888T PT 14152188 T PT14152188 T PT 14152188T PT 14152188 T PT14152188 T PT 14152188T PT 2898888 T PT2898888 T PT 2898888T
Authority
PT
Portugal
Prior art keywords
iota
composition
against viral
viral conjunctivitis
carrageenan against
Prior art date
Application number
PT14152188T
Other languages
English (en)
Inventor
Grassauer Andreas
Prieschl-Grassauer Eva
König-Schuster Marielle
Morokutti-Kurz Martina
Nakowitsch Sabine
Bodenteich Angelika
KOLLER Christiane
Original Assignee
Visufarma B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visufarma B V filed Critical Visufarma B V
Publication of PT2898888T publication Critical patent/PT2898888T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731Carrageenans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PT14152188T 2014-01-22 2014-01-22 Composição que compreende iota-carragenina contra conjuntivite viral PT2898888T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14152188.0A EP2898888B8 (en) 2014-01-22 2014-01-22 Composition comprising iota-carrageenan against viral Conjunctivitis

Publications (1)

Publication Number Publication Date
PT2898888T true PT2898888T (pt) 2019-07-16

Family

ID=49956098

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14152188T PT2898888T (pt) 2014-01-22 2014-01-22 Composição que compreende iota-carragenina contra conjuntivite viral

Country Status (15)

Country Link
US (1) US10220055B2 (pt)
EP (2) EP2898888B8 (pt)
JP (1) JP6635343B2 (pt)
CN (1) CN105939720B (pt)
CA (1) CA2937402C (pt)
DK (1) DK2898888T3 (pt)
ES (2) ES2734269T3 (pt)
HR (1) HRP20191050T1 (pt)
HU (1) HUE044329T2 (pt)
MX (1) MX2016009475A (pt)
PL (1) PL2898888T3 (pt)
PT (1) PT2898888T (pt)
RS (1) RS58731B1 (pt)
SI (1) SI2898888T1 (pt)
WO (2) WO2015110430A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3353304B1 (en) * 2015-09-25 2022-10-19 Okogen, Inc. Viral conjunctivitis treatment using ranpirnase

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
FR2653021A1 (fr) * 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
DK0495421T3 (da) * 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
DE10352137A1 (de) 2003-11-04 2005-06-16 Beschorner, Katharina, Dr. Verwendung sulfatierter Hyaluronsäure
DE102005046769A1 (de) 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
CA2651868C (en) * 2006-05-13 2014-11-25 Lg Electronics Inc. Method of performing procedures for initial network entry and handover in a broadband wireless access system
PL2101792T3 (pl) * 2006-12-05 2010-11-30 Marinomed Biotechnologie Gmbh Zastosowanie karageniny do leczenia zakażeń rinowirusem
BRPI0815748B8 (pt) 2007-08-24 2021-05-25 Marinomed Biotechnologie Gmbh uso de iota-carragenina em uma quantidade antiviral eficaz
US9481856B2 (en) 2008-06-09 2016-11-01 Bausch & Lomb Incorporated Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide
EP2303287B1 (en) * 2008-07-01 2013-12-11 Marinomed Biotechnologie GmbH Antiallergic marine biopolymers
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
NZ599839A (en) 2009-12-22 2014-02-28 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
US9161923B2 (en) * 2010-07-02 2015-10-20 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
CN102988280B (zh) * 2012-10-08 2014-03-19 新乡医学院 一种加雷沙星滴眼剂

Also Published As

Publication number Publication date
DK2898888T3 (da) 2019-06-03
CN105939720A (zh) 2016-09-14
EP3096766B1 (en) 2020-02-26
ES2791360T3 (es) 2020-11-04
CA2937402C (en) 2022-07-12
MX2016009475A (es) 2017-01-16
HUE044329T2 (hu) 2019-10-28
JP6635343B2 (ja) 2020-01-22
CN105939720B (zh) 2020-01-31
EP2898888B1 (en) 2019-04-24
EP3096766A1 (en) 2016-11-30
JP2017503841A (ja) 2017-02-02
US20160331776A1 (en) 2016-11-17
WO2015110429A1 (en) 2015-07-30
PL2898888T3 (pl) 2019-09-30
EP2898888A1 (en) 2015-07-29
ES2734269T3 (es) 2019-12-05
US10220055B2 (en) 2019-03-05
CA2937402A1 (en) 2015-07-30
RS58731B1 (sr) 2019-06-28
WO2015110430A1 (en) 2015-07-30
EP2898888B8 (en) 2019-06-12
SI2898888T1 (sl) 2019-06-28
HRP20191050T1 (hr) 2019-09-06

Similar Documents

Publication Publication Date Title
HUE054514T2 (hu) Kemence
HK1218859A1 (zh) 組合物
HK1214967A1 (zh) 組合物
SG11201704735WA (en) Composition
ZA201702830B (en) Brazing sheet
GB201403017D0 (en) Composition
GB201402169D0 (en) Viral inhibitors
SG10201507112YA (en) Furnace
HK1244432A1 (zh) 組合物
GB201414910D0 (en) Composition
ZA201704464B (en) Composition
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
GB2530668B (en) Stove
GB201519442D0 (en) Composition
ZA201606127B (en) Composition
PL2898888T3 (pl) Kompozycja zawierająca jota-karagenian przeciwko wirusowemu zapaleniu spojówek
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
IL250781A0 (en) preparation
GB201503484D0 (en) Composition
GB201502355D0 (en) Composition